2Steg PG,James SK,Atar D. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J].{H}EUROPEAN HEART JOURNAL,2012,(20):2569-2619.
3Hanley JA,McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve[J].{H}RADIOLOGY,1982,(4):29-36.
4Takahashi H,Lwanaga Y,Aoyama T. High-sensitive Ccreative Protein (CRP) assay-a novel method for assessment of risk rations for atherosclerotic vascular disease[J].Jap J Clinical Pathology,2002,(1):30-39.
5Hong T,Liu A,Cai D. Preoperative serum C-reactive protein levels and early breast cancer by BMI and menopausal status[J].{H}CANCER INVESTIGATION,2013,(4):279-285.
6Conrado E,Rizzo M,Coppola G. An update on the role of markers of inflammation in atherosclerosis[J].{H}Journal of Atherosclerosis and Thrombosis,2010,(1):1-11.
7Kim H,Yang DH,Park Y. Incremental prognostic value of Creactive protein and N-terminal proB-type natriuretic peptide in acute coronary syndrome[J].{H}CIRCULATION JOURNAL,2006,(11):1379-1384.
8Nozari Y,Geraiely B. Correlation between the serum levels of uric acid and HS-CRP with the occurrence of early systolic failure of left ventricle following acute myocardial infarction[J].{H}Acta Medica Iranica,2011,(8):531-535.
9Foussas SG,Zairis MN,Makrygiannis SS. The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction[J].{H}HEART,2007,(8):952-956.
10Arroyo-Esplignero R,Avanzas P,Quiles J. C-reactive protein predicts functional status and correlates with left ventricular ejection fraction in patients with chronic stable angina[J].{H}ATHEROSCLEROSIS,2009,(1):319-324.
